# Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

> **NCT06567197** · — · RECRUITING · sponsor: **Amsterdam UMC, location VUmc** · enrollment: 24 (estimated)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06567197
- **Lead sponsor:** Amsterdam UMC, location VUmc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-25
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06567197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06567197, "Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06567197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*